ATE503461T1 - Pharmazeutische zusammensetzungen zur behandlung von asthma - Google Patents

Pharmazeutische zusammensetzungen zur behandlung von asthma

Info

Publication number
ATE503461T1
ATE503461T1 AT09006110T AT09006110T ATE503461T1 AT E503461 T1 ATE503461 T1 AT E503461T1 AT 09006110 T AT09006110 T AT 09006110T AT 09006110 T AT09006110 T AT 09006110T AT E503461 T1 ATE503461 T1 AT E503461T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
treating asthma
asthma
treating
pharmaceutical
Prior art date
Application number
AT09006110T
Other languages
English (en)
Inventor
Joel A Sequeira
Stefan A Sharpe
John L Hart
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23224164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE503461(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE503461T1 publication Critical patent/ATE503461T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT09006110T 2001-08-28 2002-08-27 Pharmazeutische zusammensetzungen zur behandlung von asthma ATE503461T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31538601P 2001-08-28 2001-08-28

Publications (1)

Publication Number Publication Date
ATE503461T1 true ATE503461T1 (de) 2011-04-15

Family

ID=23224164

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09006110T ATE503461T1 (de) 2001-08-28 2002-08-27 Pharmazeutische zusammensetzungen zur behandlung von asthma
AT02753549T ATE430555T1 (de) 2001-08-28 2002-08-27 Pharmazeutische zusammensetzungen zur behandlung von asthma

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02753549T ATE430555T1 (de) 2001-08-28 2002-08-27 Pharmazeutische zusammensetzungen zur behandlung von asthma

Country Status (26)

Country Link
US (3) US20030114428A1 (de)
EP (3) EP2092935B1 (de)
JP (3) JP2005502675A (de)
KR (1) KR100970531B1 (de)
CN (2) CN1649568B (de)
AR (1) AR036358A1 (de)
AT (2) ATE503461T1 (de)
AU (1) AU2002313828B2 (de)
BR (1) BR0212089A (de)
CA (1) CA2457926A1 (de)
CO (1) CO5560551A2 (de)
CY (2) CY1109212T1 (de)
DE (2) DE60232251D1 (de)
DK (2) DK2092935T3 (de)
ES (3) ES2361805T3 (de)
HU (1) HUP0401514A3 (de)
MX (1) MXPA04001875A (de)
NO (1) NO20041277L (de)
NZ (1) NZ530987A (de)
PE (1) PE20030390A1 (de)
PL (1) PL209640B1 (de)
PT (2) PT2092935E (de)
SI (2) SI1420759T1 (de)
TW (1) TWI324934B (de)
WO (1) WO2003020253A2 (de)
ZA (1) ZA200401419B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
NZ528640A (en) * 2001-03-30 2004-06-25 Jagotec Ag Medical aerosol formulations
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
WO2004018025A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions
EP1785156B1 (de) * 2002-08-23 2012-06-27 Schering Corporation Aerosolhaltiger pharmazeutischer Dosierinhalator
DK1542904T3 (da) * 2002-08-27 2008-04-21 Schering Corp Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
KR20060106823A (ko) * 2003-10-20 2006-10-12 쉐링 코포레이션 약제학적 에어로졸 조성물
EP1925293A3 (de) * 2003-10-20 2010-01-13 Schering Corporation Pharmazeutische Aerosol-Zusammensetzungen
DE602005020113D1 (de) * 2004-01-21 2010-05-06 Schering Corp Verfahren zur behandlung von akuten rhinosinusitis
US20110053999A1 (en) 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
EP1811981B1 (de) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
EP2484382A1 (de) 2005-03-30 2012-08-08 Schering Corporation Medikament enthaltend einem Phosphodiesterase IV Inhibitor in einer zur Inhalation geeigneten Form
CA2641616A1 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
EP2444080A3 (de) * 2007-02-09 2012-05-02 Schering Corporation Stabile pharmazeutische Wirkstoff-Aerosole
GB0714239D0 (en) * 2007-07-20 2007-08-29 Glaxo Group Ltd Method
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
EP2244692A2 (de) * 2008-01-10 2010-11-03 Schering Corporation Inhalationsarzneimittel, systeme und verwendung
GB0801876D0 (en) 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
MX337126B (es) 2009-05-29 2016-02-12 Pearl Therapeutics Inc Administracion respiratoria de agentes activos.
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2467136B1 (de) * 2009-12-07 2014-05-07 Raptor Therapeutics Inc. 4-methylpyrazol-formulierungen
WO2011101830A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
WO2011101828A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sidium fusidate and incorporating a biopolymer and betamethasone, and a process to make it
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012017368A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
WO2012049543A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
RU2629085C2 (ru) * 2011-10-11 2017-08-24 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Кристаллические микрочастицы бета-агониста, покрытые жирной кислотой
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
KR102391332B1 (ko) 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
EP3030298B1 (de) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Vernebler
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
EA035261B1 (ru) 2014-05-07 2020-05-21 Бёрингер Ингельхайм Интернациональ Гмбх Небулайзер и контейнер
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
CN106573082B (zh) 2014-06-30 2020-01-17 普罗沃锐斯科学有限公司 用于确定药物的递送剂量的量和均匀性的采样装置及相关方法
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3556348B1 (de) 2015-12-04 2021-02-03 Mexichem Fluor S.A. de C.V. Pharmazeutische zusammensetzung
CA3016890A1 (en) 2016-03-09 2017-09-14 Proveris Scientific Corporation Methods for measuring dose content uniformity performance of inhaler and nasal devices
CN106619658B (zh) * 2016-12-28 2022-02-08 四川普锐特药业有限公司 一种医用气溶胶制剂及定量吸入气雾剂
WO2021219495A1 (en) 2020-04-28 2021-11-04 Dalcor Pharma Uk Ltd., Leatherhead, Zug Branch Methods for treating or preventing a viral infection or inhibiting viral replication
CN116583316A (zh) 2020-10-15 2023-08-11 普罗沃锐斯科学有限公司 用于吸入器测试的系统和方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
ZA924164B (en) * 1991-06-10 1993-02-24 Schering Corp Non-chlorofluorocarbon aerosol formulations
US6250300B1 (en) * 1992-12-11 2001-06-26 Ab Astra System for dispensing pharmaceutically active compounds
EP0806940B1 (de) * 1994-12-22 2003-04-09 AstraZeneca AB Aerosol-arzneiformulierungen
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
SK282147B6 (sk) * 1996-08-29 2001-11-06 Schering Corporation Aerosólový suspenzačný prípravok a jeho použitie
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
WO2000030654A1 (en) * 1998-11-26 2000-06-02 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
JP2003535042A (ja) * 2000-01-20 2003-11-25 バジリア ファルマスーチカ アーゲー 鼻腔に投与可能な環式ペプチド組成物
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
TW200301698A (en) * 2001-12-21 2003-07-16 Bristol Myers Squibb Co Acridone inhibitors of IMPDH enzyme

Also Published As

Publication number Publication date
EP2092935A1 (de) 2009-08-26
JP2005502675A (ja) 2005-01-27
PL209640B1 (pl) 2011-09-30
TWI324934B (en) 2010-05-21
NZ530987A (en) 2006-08-31
HK1060972A1 (en) 2004-09-03
ES2361805T3 (es) 2011-06-22
US20050147565A1 (en) 2005-07-07
SI1420759T1 (sl) 2009-10-31
CA2457926A1 (en) 2003-03-13
KR100970531B1 (ko) 2010-07-16
JP5170789B2 (ja) 2013-03-27
ZA200401419B (en) 2005-01-26
CN101856362A (zh) 2010-10-13
EP1420759A2 (de) 2004-05-26
KR20040031002A (ko) 2004-04-09
JP2009185075A (ja) 2009-08-20
BR0212089A (pt) 2004-08-03
US20100143269A1 (en) 2010-06-10
EP1420759B1 (de) 2009-05-06
PL368897A1 (en) 2005-04-04
EP2092935B1 (de) 2011-03-30
CY1109212T1 (el) 2014-07-02
CY1111726T1 (el) 2015-10-07
HK1128428A1 (en) 2009-10-30
EP2319494A1 (de) 2011-05-11
HK1151987A1 (en) 2012-02-17
DE60232251D1 (de) 2009-06-18
WO2003020253A3 (en) 2003-05-22
DK2092935T3 (da) 2011-07-18
AR036358A1 (es) 2004-09-01
ES2325316T3 (es) 2009-09-01
WO2003020253A2 (en) 2003-03-13
DK1420759T3 (da) 2009-08-03
HUP0401514A3 (en) 2012-08-28
ES2389480T3 (es) 2012-10-26
PE20030390A1 (es) 2003-04-24
MXPA04001875A (es) 2004-06-15
CN1649568B (zh) 2010-10-27
NO20041277L (no) 2004-03-26
SI2092935T1 (sl) 2011-07-29
AU2002313828B2 (en) 2005-09-08
US20030114428A1 (en) 2003-06-19
HUP0401514A2 (hu) 2004-12-28
EP2319494B1 (de) 2012-06-13
DE60239648D1 (de) 2011-05-12
JP2010138184A (ja) 2010-06-24
PT2092935E (pt) 2011-05-31
CN1649568A (zh) 2005-08-03
PT1420759E (pt) 2009-06-30
ATE430555T1 (de) 2009-05-15
CO5560551A2 (es) 2005-09-30

Similar Documents

Publication Publication Date Title
ATE503461T1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
FI20011478L (fi) Farmaseuttinen koostumus
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
DE60103137D1 (de) Impstoff zur behandlung von atherosclerosis
DE60211740D1 (de) Zusammensetzung zur saatgutbehandlung
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60132600D1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
ATE414512T1 (de) Kombinationstherapie zur behandlung von krebs
IS7051A (is) Lyfjasamsetningar
FI20022128A0 (fi) Farmaseuttinen koostumus
EP1408896A4 (de) Pharmazeutische zusammensetzung
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
ATE274044T1 (de) Zusammensetzungen zur behandlung von gewebe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2092935

Country of ref document: EP